MARATTO

article · Afro-Egyptian Journal of Infectious and Endemic Diseases

The Prevalence of Hepatitis C Infection among Kafr El-Sheikh University Students after Egypt's Successful National Eradication Campaign

Abstract

Background and study aim: Egypt had the highest worldwide prevalence of the hepatitis C virus during the last few years. The aim of our research was to determine the seroprevalence of hepatitis C virus among college students at Kafr El-Sheikh University after mass treatment of Egyptian population.Patients and Methods: Six thousand students were enrolled in this research. The data were taken, including exposure to risk factors of hepatitis C infection, family history of hepatitis C, and the history of previous treatment of hepatitis C. All students were tested for hepatitis C virus antibody. HCV‐RNA by polymerase chain reaction was performed for students with detectable hepatitis C virus antibody.Results: The mean age of the studied group was 19.41 ± 1.23 years. In total, 4356 (72.6%) were females and 1644 (27.4%) were males. Two students (0.03%) had positive hepatitis C virus antibody with undetectable HCV RNA. They were two females aged 18 and 21 years old. Both had a history of dental procedures and a family history of hepatitis C infection. However, one of them was previously treated for hepatitis C with direct-acting antiviral drugs.Conclusion: There was low prevalence of hepatitis C virus infection among the new students in Kafr Elsheikh University, and this might be a result of generalized decline of hepatitis C virus infection prevalence in Egypt due to successful control.

Research topics

  • Hepatitis C virus research
  • Hepatitis B Virus Studies
  • Liver Disease Diagnosis and Treatment

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/aeji.2025.395341.1489

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.